Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Shares of Kenvue rose more than 5% in premarket trading Monday after The Wall Street Journal reported that activist investor Starboard Value has built a sizable stake in the consumer-products maker ...